AWSHX
Price
$67.56
Change
+$0.42 (+0.63%)
Updated
Jul 24 closing price
Net Assets
219.02B
GPAFX
Price
$63.62
Change
+$0.46 (+0.73%)
Updated
Jul 24 closing price
Net Assets
561.33M
Interact to see
Advertisement

AWSHX vs GPAFX

AWSHX vs GPAFX Comparison Chart in %
View a ticker or compare two or three
VS
AWSHX vs. GPAFX commentary
Jul 26, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AWSHX is a Buy and GPAFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AWSHX has more cash in the bank: 219B vs. GPAFX (561M). AWSHX pays higher dividends than GPAFX: AWSHX (1.22) vs GPAFX (0.79). AWSHX was incepted earlier than GPAFX: AWSHX (74 years) vs GPAFX (54 years). GPAFX (0.90) is less costly to investors than AWSHX (0.55). GPAFX is a more actively managed with annual turnover of: 44.00 vs. AWSHX (29.00). AWSHX (6%) and GPAFX (6%) have equivalent initial investment costs. AWSHX has a lower initial minimum investment than GPAFX: AWSHX (250) vs GPAFX (2500). GPAFX annual gain was more profitable for investors over the last year : 6.31 vs. AWSHX (5.14). AWSHX return over 5 years is better than : 26.98 vs. GPAFX (13.17).
AWSHXGPAFXAWSHX / GPAFX
Total Expense Ratio0.550.8962%
Annual Report Gross Expense Ratio0.550.9061%
Fund Existence74 years54 years-
Gain YTD4.2427.63056%
Front Load6%6%100%
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets219B561M39,037%
Annual Yield % from dividends1.220.79154%
Returns for 1 year5.146.3182%
Returns for 3 years26.5127.2597%
Returns for 5 years26.9813.17205%
Returns for 10 years76.0131.29243%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ENVA237.2719.47
+8.94%
Enova International
CURV2.480.11
+4.64%
Torrid Holdings
AFYA13.900.14
+1.02%
Afya Limited
SNY43.35-0.01
-0.02%
Sanofi ADS
SKYE0.65-0.02
-3.42%
Skye Bioscience